A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors
DualityBio Inc.
DualityBio Inc.
Pfizer
Nektar Therapeutics
Kiadis Pharma
NKGen Biotech, Inc.
Southwest Hospital, China
Rexahn Pharmaceuticals, Inc.
Fred Hutchinson Cancer Center